Literature DB >> 20223995

Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.

Markus Velten1, Kathryn M Heyob, Lynette K Rogers, Stephen E Welty.   

Abstract

Systemic maternal inflammation contributes to preterm birth and is associated with development of bronchopulmonary dysplasia (BPD). Infants with BPD exhibit decreased alveolarization, diffuse interstitial fibrosis with thickened alveolar septa, and impaired pulmonary function. We tested the hypothesis that systemic prenatal LPS administration to pregnant mice followed by postnatal hyperoxia exposure is associated with prolonged alterations in pulmonary structure and function after return to room air (RA) that are more severe than hyperoxia exposure alone. Timed-pregnant C3H/HeN mice were dosed with LPS (80 microg/kg) or saline on gestation day 16. Newborn pups were exposed to RA or 85% O2 for 14 days and then to RA for an additional 14 days. Data were collected and analyzed on postnatal days 14 and 28. The combination of prenatal LPS and postnatal hyperoxia exposure generated a phenotype with more inflammation (measured as no. of macrophages per high-power field) than either insult alone at day 28. The combined exposures were associated with a diffuse fibrotic response [measured as hydroxyproline content (microg)] but did not induce a more severe developmental arrest than hyperoxia alone. Pulmonary function tests indicated that hyperoxia, independent of maternal exposure, induced compliance decreases on day 14 that did not persist after RA recovery. Either treatment alone or combined induced an increase in resistance on day 14, but the increase persisted on day 28 only in pups receiving the combined treatment. In conclusion, the combination of systemic maternal inflammation and neonatal hyperoxia induced a prolonged phenotype of arrested alveolarization, diffuse fibrosis, and impaired lung mechanics that mimics human BPD. This new model should be useful in designing studies of specific mechanisms and interventions that could ultimately be utilized to define therapies to prevent BPD in premature infants.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223995      PMCID: PMC2867533          DOI: 10.1152/japplphysiol.01392.2009

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  37 in total

Review 1.  The new BPD: an arrest of lung development.

Authors:  A J Jobe
Journal:  Pediatr Res       Date:  1999-12       Impact factor: 3.756

Review 2.  The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes.

Authors:  Sven Cnattingius
Journal:  Nicotine Tob Res       Date:  2004-04       Impact factor: 4.244

Review 3.  Mechanotransduction determines the structure and function of lung and bone: a theoretical model for the pathophysiology of chronic disease.

Authors:  J S Torday; V K Rehan
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

4.  Selective staining of human dermal collagen. II. The use of picrosirius red F3BA with polarization microscopy.

Authors:  V S Constantine; R W Mowry
Journal:  J Invest Dermatol       Date:  1968-05       Impact factor: 8.551

Review 5.  Determination of hydroxyproline.

Authors:  H Stegemann; K Stalder
Journal:  Clin Chim Acta       Date:  1967-11       Impact factor: 3.786

6.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

7.  Differential staining of collagens type I, II and III by Sirius Red and polarization microscopy.

Authors:  L C Junqueira; W Cossermelli; R Brentani
Journal:  Arch Histol Jpn       Date:  1978-06

8.  Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation.

Authors:  Irina A Buhimschi; Catalin S Buhimschi; Carl P Weiner
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

9.  Hyperoxia exposure alters hepatic eicosanoid metabolism in newborn mice.

Authors:  Lynette K Rogers; Trent E Tipple; Rodney D Britt; Stephen E Welty
Journal:  Pediatr Res       Date:  2010-02       Impact factor: 3.756

Review 10.  Antenatal infection/inflammation and postnatal lung maturation and injury.

Authors:  A H Jobe; M Ikegami
Journal:  Respir Res       Date:  2001-01-11
View more
  58 in total

1.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia.

Authors:  Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

Review 2.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

3.  Severity of neonatal hyperoxia determines structural and functional changes in developing mouse airway.

Authors:  Hua Wang; Anjum Jafri; Richard J Martin; Jerry Nnanabu; Carol Farver; Y S Prakash; Peter M MacFarlane
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-20       Impact factor: 5.464

4.  Maternal dietary docosahexaenoic acid supplementation attenuates fetal growth restriction and enhances pulmonary function in a newborn mouse model of perinatal inflammation.

Authors:  Markus Velten; Rodney D Britt; Kathryn M Heyob; Trent E Tipple; Lynette K Rogers
Journal:  J Nutr       Date:  2014-01-22       Impact factor: 4.798

5.  Hyperoxia exposure disrupts adrenomedullin signaling in newborn mice: Implications for lung development in premature infants.

Authors:  Renuka T Menon; Amrit Kumar Shrestha; Binoy Shivanna
Journal:  Biochem Biophys Res Commun       Date:  2017-04-21       Impact factor: 3.575

6.  Of mice and men: correlations between microRNA-17∼92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia.

Authors:  Mary E Robbins; Duaa Dakhlallah; Clay B Marsh; Lynette K Rogers; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

7.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

8.  Maternal pre-gravid obesity and early childhood respiratory hospitalization: a population-based case-control study.

Authors:  Elizabeth C Parsons; Kevin Patel; Betty T Tran; Alyson J Littman
Journal:  Matern Child Health J       Date:  2013-08

Review 9.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Vineet Bhandari
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

10.  Perinatal inflammation results in decreased oligodendrocyte numbers in adulthood.

Authors:  Amanda E Graf; Krista M Haines; Christopher R Pierson; Brad N Bolon; Ronald H Houston; Markus Velten; Kathryn M Heyob; Lynette K Rogers
Journal:  Life Sci       Date:  2013-11-28       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.